Apremilast as Anti-pruritic Treatment in Patients With Prurigo Nodularis
NCT03576287
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Prurigo Nodularis
Interventions
DRUG:
Apremilast Oral Product
Sponsor
Tanja Todberg, MD